A
Andrea Treszl
Researcher at University of Debrecen
Publications - 20
Citations - 452
Andrea Treszl is an academic researcher from University of Debrecen. The author has contributed to research in topics: Receptor & Fluorescence in situ hybridization. The author has an hindex of 12, co-authored 20 publications receiving 426 citations. Previous affiliations of Andrea Treszl include United States Department of Veterans Affairs & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization.
TL;DR: It is found that the pattern of chromosomal aberrations is similar in the two subgroups; however, alterations present only in primary and/or metastatic tumors were also discovered.
Journal ArticleDOI
Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.
Márk Barok,Margit Balázs,Péter Nagy,Zsuzsa Rákosy,Andrea Treszl,Eniko Toth,István Juhász,John W. Park,Jorma Isola,György Vereb,János Szöllosi +10 more
TL;DR: It is shown that trastuzumab significantly reduces the number of circulating and disseminated tumor cells (CTCs and DTCs) in this xenograft model system at a time when the primary tumor is already unresponsive to trastzumab.
Journal ArticleDOI
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues
Christian G. Ziegler,Jacqueline T. Brown,Andrew V. Schally,A Erler,Linda Gebauer,Andrea Treszl,Louise Young,L M Fishman,J B Engel,Holger S. Willenberg,S Petersenn,Graeme Eisenhofer,Monika Ehrhart-Bornstein,Stefan R. Bornstein +13 more
TL;DR: The expression of receptors for somatostatin, GHRH, and LHRH in the normal human adrenal and in adrenal tumors, combined with the growth-inhibitory effects of the antitumor peptide analogues, may make possible improved treatment approaches to Adrenal tumors.
Journal ArticleDOI
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers
Stephan Seitz,Ferenc G. Rick,Andrew V. Schally,Andrea Treszl,F. Hohla,Luca Szalontay,Marta Zarandi,Olaf Ortmann,JB Engel,Stefan Buchholz +9 more
TL;DR: In this paper, the authors investigated the effectiveness of the treatment of MDA-MB-231 human triple-negative breast cancer (TNBC) with GHRH antagonist JMR-132 alone or in combination with docetaxel.
Journal ArticleDOI
Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.
Andrea Treszl,Róza Ádány,Zsuzsa Rákosy,László Kardos,Ágnes Bégány,Katalin Gilde,Margit Balázs +6 more
TL;DR: This work investigated the c‐myc copy number alterations in two different subtypes of primary melanomas with different biological behaviours.